Lanny Sun
CEO
Full-Life Technologies
Full-Life Technologies develops and commercializes targeted therapies for cancer treatment, focusing on the formulation and production of novel pharmaceutical compounds. The company addresses the need for effective cancer medications that improve patient outcomes and reduce side effects associated with traditional therapies.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$47.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
HH Ting
Co-founder & Chief Strategy Officer
Product
Problem
Many existing cancer treatments have significant side effects and limited efficacy, highlighting the need for more targeted and effective therapies. Traditional cancer treatments often harm healthy cells along with cancerous ones, leading to debilitating side effects and reduced quality of life for patients. The development of novel pharmaceutical compounds is crucial for improving patient outcomes and minimizing adverse effects.
Solution
Full-Life Technologies focuses on developing and commercializing targeted cancer therapies designed to improve patient outcomes while minimizing side effects. The company formulates and produces novel pharmaceutical compounds that selectively target cancer cells, reducing harm to healthy tissues. By focusing on targeted drug delivery and innovative therapeutic approaches, Full-Life Technologies aims to enhance the effectiveness of cancer treatment and improve the overall well-being of patients undergoing therapy. Their approach seeks to address the limitations of traditional chemotherapy and radiation by providing more precise and personalized treatment options. This allows for a more effective and tolerable treatment experience for cancer patients.
Target Audience
Full-Life Technologies primarily targets oncologists, hospitals, and cancer treatment centers seeking advanced and targeted therapeutic options for their patients.
Features
- Development of targeted therapies that selectively attack cancer cells.
- Formulation of novel pharmaceutical compounds with enhanced efficacy.
- Focus on minimizing side effects associated with traditional cancer treatments.
- Research and development of innovative drug delivery systems.
- Clinical trials to evaluate the safety and effectiveness of new therapies.